Extension Study of IONIS-GHR-LRx Administered to Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

Condition:   Acromegaly Interventions:   Drug: IONIS GHR-LRx;   Drug: SRL Sponsor:   Ionis Pharmaceuticals, Inc. Not yet recruiting

Source: ClinicalTrials.gov - May 30, 2019 Category: Research Source Type: clinical trials